INVISTA joins CPI for development of new technologies to enable gas-fermentation-based processes

Published on December 10, 2013 at 6:48 AM · No Comments

INVISTA and The Centre for Process Innovation (CPI) announce a collaboration for the development of new technologies to enable gas-fermentation-based processes for the production of industrial chemicals.

The collaboration will leverage INVISTA's capabilities in biotechnology and catalysis, and knowledge of the chemicals industry, along with CPI's applied knowledge in science and engineering and capabilities in new process/product development and scale-up for the development of new gas-fermentation-based routes to industrial chemicals.

"INVISTA believes biotechnology has the potential to significantly improve the cost and availability of several chemicals and raw materials that are used to produce its current products," said Warren Primeaux, president of INVISTA Intermediates. "We see gas fermentation as a key enabling technology that will allow the use of potentially advantaged gas feedstocks such as waste industrial gases. CPI's excellent capabilities and facilities are additive to our own, and we are pleased to announce this exciting collaboration."

Nigel Perry, CEO of CPI said, "Following the recent and significant advances in the field of Synthetic Biology, CPI believes that gas-fermentation technology holds great promise to unlock the economic production of commodity products. We are looking forward to collaborating on this venture which will leverage the synergy between the leading positions of INVISTA and CPI."

Source: The Centre for Process Innovation

Posted in: Business / Finance | Device / Technology News

Tags: ,

Read in | English | Español | Français | Deutsch | Português | Italiano | 日本語 | 한국어 | 简体中文 | 繁體中文 | Nederlands | Русский | Svenska | Polski
Comments
The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News-Medical.Net.
Post a new comment
Post